Wells Fargo analyst Jamie Stockton maintained a Hold rating on Tabula Rasa HealthCare (TRHC) today. The company’s shares opened today at $57.
According to TipRanks.com, Stockton is ranked #1434 out of 5224 analysts.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Tabula Rasa HealthCare with a $90.20 average price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $91.16 and a one-year low of $30.56. Currently, Tabula Rasa HealthCare has an average volume of 351.4K.
Based on the recent corporate insider activity of 82 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Tabula Rasa Healthcare, Inc. engages in the development of pharmaceutical software that optimizes medication regimens. It offers cloud-based applications, such as EireneRx and MedWise Advisor. The company was founded by Calvin H. Knowlton and Orsula V. Knowlton in April 2009 and is headquartered in Moorestown, NJ.
